Search

Coronavirus is one of the serious threat and challenge for existing healthcare systems. Several prevention methods and precautions have been proposed by medical specialists to treat the virus and secure infected patients. Deep learning methods have been adopted for disease detection, especially for medical image classification. In this paper, we proposed a deep learning-based medical image classification for COVID-19 patients namely deep learning model for coronavirus (DLM-COVID-19). The proposed model improves the medical image classification and optimization for better disease diagnosis. This paper also proposes a mobile application for COVID-19 patient detection using a self-assessment test combined with medical expertise and diagnose and prevent the virus using the online system. The proposed deep learning model is evaluated with existing algorithms where it shows better performance in terms of sensitivity, specificity, and accuracy. Whereas the proposed application also helps to overcome the virus risk and spread.

Background and aims Artificial Intelligence (AI) shows extensive capabilities to impact different healthcare areas during the COVID-19 pandemic positively. This paper tries to assess the capabilities of AI in the field of cardiology during the COVID-19 pandemic. This technology is useful to provide advanced technology-based treatment in cardiology as it can help analyse and measure the functioning of the human heart. Methods We have studied a good number of research papers on Artificial Intelligence on cardiology during the COVID-19 pandemic to identify its significant benefits, applications, and future scope. AI uses artificial neuronal networks (ANN) to predict. In cardiology, it is used to predict the survival of a COVID-19 patient from heart failure. Results AI involves complex algorithms for predicting somewhat successful diagnosis and treatments. This technology uses different techniques, such as cognitive computing, deep learning, and machine learning. It is incorporated to make a decision and resolve complex challenges. It can focus on a large number of diseases, their causes, interactions, and prevention during the COVID-19 pandemic. This paper introduces AI-based care and studies its need in the field of cardiology. Finally, eleven major applications of AI in cardiology during the COVID-19 pandemic are identified and discussed. Conclusions Cardiovascular diseases are one of the major causes of death in human beings, and it is increasing for the last few years. Cardiology patients' treatment is expensive, so this technology is introduced to provide a new pathway and visualise cardiac anomalies. AI is used to identify novel drug therapies and improve the efficiency of a physician. It is precise to predict the outcome of the COVID-19 patient from cardiac-based algorithms. Artificial Intelligence is becoming a popular feature of various engineering and healthcare sectors, is thought for providing a sustainable treatment platform. During the COVID-19 pandemic, this technology digitally controls some processes of treatments.

The Coronavirus disease 2019 (COVID-19) is an infectious disease spreading rapidly and uncontrollably throughout the world. The critical challenge is the rapid detection of Coronavirus infected people. The available techniques being utilized are body-temperature measurement, along with anterior nasal swab analysis. However, taking nasal swabs and lab testing are complex, intrusive, and require many resources. Furthermore, the lack of test kits to meet the exceeding cases is also a major limitation. The current challenge is to develop some technology to non-intrusively detect the suspected Coronavirus patients through Artificial Intelligence (AI) techniques such as deep learning (DL). Another challenge to conduct the research on this area is the difficulty of obtaining the dataset due to a limited number of patients giving their consent to participate in the research study. Looking at the efficacy of AI in healthcare systems, it is a great challenge for the researchers to develop an AI algorithm that can help health professionals and government officials automatically identify and isolate people with Coronavirus symptoms. Hence, this paper proposes a novel method CoVIRNet (COVID Inception-ResNet model), which utilizes the chest X-rays to diagnose the COVID-19 patients automatically. The proposed algorithm has different inception residual blocks that cater to information by using different depths feature maps at different scales, with the various layers. The features are concatenated at each proposed classification block, using the average-pooling layer, and concatenated features are passed to the fully connected layer. The efficient proposed deep-learning blocks used different regularization techniques to minimize the overfitting due to the small COVID-19 dataset. The multiscale features are extracted at different levels of the proposed deep-learning model and then embedded into various machine-learning models to validate the combination of deep-learning and machine-learning models. The proposed CoVIR-Net model achieved 95.7% accuracy, and the CoVIR-Net feature extractor with random-forest classifier produced 97.29% accuracy, which is the highest, as compared to existing state-of-the-art deep-learning methods. The proposed model would be an automatic solution for the assessment and classification of COVID-19. We predict that the proposed method will demonstrate an outstanding performance as compared to the state-of-the-art techniques being used currently.

Stroke is one of the prime reasons for paralysis throughout the world caused due to impaired nervous system and resulting in disability to move the affected body parts. Rehabilitation is the natural remedy for recovering from paralysis and enhancing the quality of life. Brain Computer Interface (BCI) controlled assistive technology is the new paradigm, providing assistance and rehabilitation for the paralysed. But, most of these devices are error prone and also hard to get continuous control because of the dynamic nature of the brain signals. Moreover, existing devices like exoskeletons brings additional burden on the patient and the caregivers and also results in mental fatigue and frustration. To solve these issues Artificial Muscle Intelligence with Deep Learning (AMIDL) system is proposed in this paper. AMIDL integrates user intentions with artificial muscle movements in an efficient way to improve the performance. Human thoughts captured using Electroencephalogram (EEG) sensors are transformed into body movements, by utilising microcontroller and Transcutaneous Electrical Nerve Stimulation (TENS) device. EEG signals are subjected to pre-processing, feature extraction and classification, before being passed on to the affected body part. The received EEG signal is correlated with the recorded artificial muscle movements. If the captured EEG signal falls below the desired level, the affected body part will be stimulated by the recorded artificial muscle movements. The system also provides a feature for communicating human intentions as alert message to caregivers, in case of emergency situations. This is achieved by offline training of specific gesture and online gesture recognition algorithm. The recognised gesture is transformed into speech, thus enabling the paralysed to express their feelings to the relatives or friends. Experiments were carried out with the aid of healthy and paralysed subjects. The AMIDL system helped to reduce mental fatigue, miss-operation, frustration and provided continuous control. The thrust of lifting the exoskeleton is also reduced by using light weight wireless electrodes. The proposed system will be a great communication aid for paralysed to express their thoughts and feelings with dear and near ones, thereby enhancing the quality of life.

The most commonly injured ligament in the human body is an anterior cruciate ligament (ACL). ACL injury is standard among the football, basketball and soccer players. The study aims to detect anterior cruciate ligament injury in an early stage via efficient and thorough automatic magnetic resonance imaging without involving radiologists, through a deep learning method. The proposed approach in this paper used a customized 14 layers ResNet-14 architecture of convolutional neural network (CNN) with six different directions by using class balancing and data augmentation. The performance was evaluated using accuracy, sensitivity, specificity, precision and F1 score of our customized ResNet-14 deep learning architecture with hybrid class balancing and real-time data augmentation after 5-fold cross-validation, with results of 0.920%, 0.916%, 0.946%, 0.916% and 0.923%, respectively. For our proposed ResNet-14 CNN the average area under curves (AUCs) for healthy tear, partial tear and fully ruptured tear had results of 0.980%, 0.970%, and 0.999%, respectively. The proposing diagnostic results indicated that our model could be used to detect automatically and evaluate ACL injuries in athletes using the proposed deep-learning approach.

The atrial fibrillation (AF) is one of the most well-known cardiac arrhythmias in clinical practice, with a prevalence of 1&ndash, 2% in the community, which can increase the risk of stroke and myocardial infarction. The detection of AF electrocardiogram (ECG) can improve the early detection of diagnosis. In this paper, we have further developed a framework for processing the ECG signal in order to determine the AF episodes. We have implemented machine learning and deep learning algorithms to detect AF. Moreover, the experimental results show that better performance can be achieved with long short-term memory (LSTM) as compared to other algorithms. The initial experimental results illustrate that the deep learning algorithms, such as LSTM and convolutional neural network (CNN), achieved better performance (10%) as compared to machine learning classifiers, such as support vectors, logistic regression, etc. This preliminary work can help clinicians in AF detection with high accuracy and less probability of errors, which can ultimately result in reduction in fatality rate.